Vilazodone regulatory update

Clinical Data submitted an NDA to FDA for vilazodone to treat major depressive disorder (MDD). Vilazodone is a mixed selective serotonin reuptake inhibitor (SSRI) and partial serotonin (5-HT1A) recep...